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Introduction 
Tattooing is defined as the process of implantation 
of exogenous inerasable pigment into the dermis of 
the skin or other parts of the body (e.g., mucosae, 
lips, eyebrows, eyes) of consumers to create a design. 
Although tattoos in most cases are decorative, they 
can also serve religious or medical purposes (e.g. 
breast reconstruction, radiotherapy), or may occur 
accidentally after injuries (traumatic tattoos). 
Particularly in the last three decades, the popularity 
of tattoos has impressively increased worldwide and 
has become mainstream at least for the young 
generation. It is estimated that more than 100 million 
European citizens and about 24% of the US 
population up to the age of 60 years have one or 
more permanent tattoos on their skin [1]. Already by 
the end of 19th century it was well known that tattoos 
may elicit a variety of mucocutaneous or systemic, 
early or delayed, acute or chronic complications. 
According to the type of reaction these 
complications can be classified as hypersensitivity or 
inflammatory reactions and as infectious, neoplastic, 
or granulomatous disorders [2]. 
Pseudoepitheliomatous hyperplasia (PEH) is a 
benign irregular hyperplasia of the epidermis that 
occurs in response to various stimuli and bears 
clinical and histopathological similarity to cutaneous 
neoplasms, such as squamous cell carcinoma (SCC) 
and keratoacanthoma [3-5]. PEH secondary to tattoo  
Abstract 
The popularity of tattoos has increased dramatically 
worldwide particularly in the last three decades, 
giving rise to the frequent occurrence of a wide 
spectrum of secondary cutaneous and systemic 
complications. Pseudoepitheliomatous hyperplasia 
(PEH) is a benign irregular hyperplasia of the 
epidermis occurring in response to various stimuli, 
that clinically and histopathologically resembles 
cutaneous neoplasms such as squamous cell 
carcinoma and keratoacanthoma. In an attempt to 
improve the awareness of the possible occurrence of 
PEH in tattoos and of its diagnostic and therapeutic 
aspects, we present herein the case of a 30-year-old 
woman with histologically confirmed PEH related to 
a red-ink tattoo. She revealed two important features: 
the longest interval reported so far between 
tattooing and onset of PEH (two years) and the lack 
of the otherwise very common lichenoid tissue 
reaction to red ink. In view of the serious toxicological 
potential of tattoo inks, implementation of updated 
and standardized regulations worldwide regarding 
their use in the tattooing process is now urgently 
warranted and continuous efforts should be 
undertaken in order to enhance the awareness 
among tattoo artists and the public with regard to 
the possible serious health risks associated with the 
use of tattoo ink pigments. 
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is a rare complication. In an attempt to improve the 
awareness among physicians of the possible 
occurrence of PEH in tattoos and of its diagnostic and 
therapeutic aspects, we present herein the case of a 
30-year-old woman with histologically confirmed 
late-onset PEH reaction to a red-ink permanent 
tattoo. 
 
Case Synopsis 
A 30-year-old HIV-negative and otherwise healthy 
woman presented to the Center for Dermatologic 
Diseases in Limassol, Cyprus, with a one-year history 
of a skin lesion progressively arising on the inner 
aspect of the ankle of her left foot on a red tattoo 
performed by a professional artist in the United 
States three years prior. She was not aware of the 
origin, the type, or the quantity of the red ink used. 
She had no history of malignancy or 
immunosuppression and received no medications 
on a daily basis. Clinical examination revealed a well-
developed woman in no acute distress that was 
remarkable for a well demarcated heart-shaped firm 
nodule (1.3cm in diameter) with a verrucous and 
partly erosive surface beneath the medial malleolus 
of the left foot (Figure 1). There was no evidence of 
lymphadenopathy and/or hepatosplenomegaly. 
Routine hematological, biochemical and serological 
tests and X-ray examination of the leg revealed 
normal or negative results. The results of 
bacteriological and mycological examination of the 
skin lesion were also negative. 
Histopathological examination of a deep biopsy 
obtained from the lesional skin revealed epidermal 
pseudoepitheliomatous hyperplasia, characterized 
by irregular acanthosis and parakeratosis. There 
were sharply pointed epithelial strands projecting 
into the underlying dermis, whereas significant 
cellular atypia was lacking and mitoses were rare. 
Prominent extracellular deposits of red exogenous 
pigment were found between collagen bundles in 
the upper and mid dermis accompanied by a mixed 
inflammatory cell infiltrate consisting of 
lymphocytes and plasma cells (Figure 2). Thus, the 
diagnosis of PEH at the site of the tattoo was 
established. The lesion was totally excised with 
excellent cosmetic results. 
 
Case Discussion 
In view of the millions of tattooed people worldwide, 
it is not surprising that tattoo-related complications 
are being increasingly encountered by dermatologists 
 
Figure 2. Pseudoepitheliomatous hyperplasia as a reaction in a 
red tattoo. The epidermis reveals a distinct hyperkeratosis, 
parakeratosis and acanthosis with sharply-pointed epithelial 
strands projecting into the underlying dermis. In the papillary 
dermis, extracellular deposits of red pigment are seen, that are 
accompanied by a mixed inflammatory cell infiltrate consisting 
of lymphocytes and plasma cells. H&E, 100×. 
 
Figure 1. Well demarcated heart-shaped firm nodule with 
verrucous and partly erosive surface beneath the medial 
malleolus of the left foot. 
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in everyday clinical practice. The prevalence of the 
reported complications varies between 2% and 27% 
[2, 6]. Nevertheless, its accurate estimation is 
presently impossible because a number of cases 
remains unreported and controlled studies on large 
numbers of individuals are still lacking. Tattoo-
related complications can be acute or have a 
protracted and chronic course [7]. Table 1 
summarizes the reported mucocutaneous and 
systemic complications of permanent tattoos. 
Table 1. Mucocutaneous and systemic adverse reactions related to permanent tattoos. 
 
A. Systemic Reactions 
[1, 2, 39-41] B. Mucocutaneous Reactions
 B1.  Hypersensitivity and 
inflammatory reactions 
[9, 11, 41-48] 
B2. Infections 
[46, 49-54] 
B3. Neoplasms  
[12, 13, 29, 46, 55-60] 
B4. Granulomatous 
Reactions  
[1, 2, 61-64]
Abdominal compartment 
syndrome  
Bacteremia 
Death 
Endocarditis 
Fat necrosis 
Fever 
Gangrene 
Iliopsoas abscess 
Latex allergy 
Lymphadenopathy 
regional or generalized 
Lymphoedema 
Multiorgan failure 
Necrotizing pneumonia 
Pyelonephritis 
Septic shock 
Spinal abscesses 
Systemic bacterial and 
viral infections 
Systemic vasculitis 
Tropical pyomyositis 
Uveitis 
Xanthogranulomatous  
 
Acute GVHD 
Angioneurotic oedema 
Bleeding / Hematoma 
Blister formation 
“Blue-foot” discoloration 
Burning sensation 
Chronic fibrosing vasculitis 
Contact dermatitis 
Contact urticaria 
Crusting 
Edematous “peau d’ orange”
Erythema multiforme 
Hypertrichosis 
Hypo- or 
hyperpigmentation 
Lichen planus and 
lichenoid lesions 
Light-induced urticaria  
Lymphoedema 
Morphea and 
scleroderma-like lesions 
Mucosal ulceration 
Necrotizing fasciitis or 
tissue necrosis 
Pain or tenderness  
Paradoxical skin darkening 
Photodermatitis 
Pigment diffusion 
Prurigo nodularis 
Pruritus 
Pseudolymphomatous lesion
Psoriasis 
Purpura / Petechiae 
Pyoderma gangrenosum 
Scarring / Keloid 
Subacute or discoid lupus 
erythematosus 
Sweet syndrome 
Swelling 
Vasculitis 
Wells syndrome 
Bacterial 
Abscesses 
Cellulitis 
Cutaneous 
diptheria 
Erysipelas 
Gangrene 
Impetigo 
Leprosy 
MRSA infections 
Non-tuberculous 
mycobacterium 
skin infections 
Staphylococcal 
scalded skin 
syndrome 
Syphilis 
Tetanus 
Tuberculosis 
 
Viral 
CMV  
Heparitis B and C  
HIV  
HPV 
HSV 
Molluscum 
contagiosum 
 
Fungal 
Aspergillosis 
Dermatophytosis 
Sporotrichosis 
Tinea cutis 
Zygomycoses 
 
Benign 
Cutaneous lymphoid 
hyperplasia 
Dermatofibroma 
Epidermal cysts 
Milia 
Seborrhoeic keratosis 
 
Malignant 
Basal cell carcinoma 
Fibrosarcoma 
protuberans 
Keratoacanthoma 
Lymphomas 
Melanoma 
Squamous cell 
carcinoma 
Foreign body reaction 
Perforating 
granulomatous reaction
Sarcoidosis 
Necrobiotic reaction 
Tuberculoid reaction 
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Cutaneous complications of red tattoos are very 
common, with allergic dermatitis, photosensitivity, 
and granulomatous adverse reactions being the 
most frequent ones [8-11]. Red inks are associated 
with 34% of post-tattoo skin cancers, 50% of SCCs, 
and 73% of keratoacanthomas [12, 13]. It is believed 
that substances contained in red inks (e.g. 2-
anisidine) function as co-carcinogens, especially in 
combination with sunlight exposure [14]. 
PEH is a benign proliferative cutaneous disorder, 
occurring in response to various stimuli, which is 
regarded as a reactive histopathological pattern 
rather than a distinct nosological entity [15]. 
Clinically PEH occurs as a nodule or plaque of various 
sizes with a verrucoid or vegetative surface, scaling, 
and possibly ulceration and crusting [16]. The main 
histopathological feature of PEH is the presence of 
follicular infundibulum-derived irregular projections 
of the epidermis extending deep into the reticular 
dermis. Orthokeratosis, parakeratosis, 
hypergranulosis, and keratin pearls are usual 
findings, whereas mitoses are sparse and not-
atypical [16]. Owing to their clinical and 
histopathological similarities, the distinction 
between PEH and SCC can be very challenging. A 
deep biopsy including the base of the lesion and 
underlying dermis is usually necessary for a definitive 
diagnosis. Important histopathological features that 
favor the diagnosis of PEH are minimal cytological 
atypia, paucity of mitotic activity, absence of atypical 
mitoses, and absence of necrotic keratinocytes or 
vascular and perineural invasion [16, 17]. 
Since the original description of PEH secondary to a 
tattoo by Sulzberger in 1937, 20 cases have been 
reported (Table 2), [17-28]. However, owing to 
substantial clinical and histopathological similarity, 
the possibility that some cases previously reported 
as keratoacanthomas or lichenoid hypersensitivity 
reactions in tattooed patients were in fact PEH 
cannot be definitely excluded [10]. Interestingly, 
almost all tattoo-related PEH cases reported so far 
were associated with the use of either red or purple 
dye. The interval between tattooing and the onset of 
PEH varies between 4 days and 12 months. In our 
patient PEH occurred two years after tattooing, the  
longest interval reported so far, to our knowledge. 
Additionally, the lichenoid tissue reaction to red ink, 
that is otherwise very common among PEH patients 
[10], was absent in our case. 
Upon transfer of the pigment into the dermis using 
an electric vibrating device, pigment granules are 
ingested by skin phagocytes and a transient 
inflammatory period of two-week duration is 
initiated that is characterized by a foreign-body 
reaction and fibrous tissue formation [4]. Finally, the 
pigment is encapsulated in dense layers of 
connective tissue mainly in the papillary dermis 
either within fibroblasts or between collagen 
bundles [11, 29]. Pigment can migrate, however, via 
lymphatics to regional lymph nodes, which in some 
cases are filled with pigment [12]. Recently, Sepehri 
et al. [30] reported the occurrence of tattoo pigments 
in the blood circulation and in the Kupffer cells of the 
mouse liver, as well. These pigments can be 
degraded under UV irradiation leading to the 
formation of toxic or carcinogenic products such as 
3, 3-dichlorobenzidine [31-35]. 
The exact pathogenetic mechanisms of PEH 
secondary to tattoos still remain unknown. Since PEH 
is specifically related to red pigment in permanent 
tattoos, it has been hypothesized that early 
inflammation triggered by the newly introduced 
exogenous pigment could result in the development 
of PEH [4]. PEH is regarded by some authors as an 
autoimmune reaction and epidermal hyperplasia as 
the result of lymphocyte-derived chemokines 
inducing keratinocyte proliferation [28]. 
The red tattoo pigmentation was traditionally 
achieved by the use of cinnabar (mercuric sulfide), a 
well-known allergen that has been implicated in 
several cases of delayed hypersensitivity reactions 
[1]. Actually, the first described case of tattoo-related 
PEH by Sulzberger [18] was associated with its use. 
Although cinnabar has been gradually replaced by 
new mercury-free red pigments such as cadmium 
red, iron oxide, ferric sulfate, hematite, cadmium 
selenide, sienna, naphthol-AS pigment, azo 
pigments (pigment red 210, 170, 112, 122), and 
quinacridones (Violet 19, red 122), [1], adverse 
reactions in red tattoo areas still continue to occur. 
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Sunlight exposure of the red tattoo areas prior of the 
occurrence of PEH is a common denominator among 
the reported cases and is considered as an additional 
pathogenetic factor for this complication [18], 
possibly through the production of toxic or 
sensitizing substances by photodegradation or 
metabolic activation of the pigment molecules. The 
tattoo of our patient was located on the ankle of her 
left foot and, thus, would likely be heavily exposed to  
sunlight. It is possible, therefore, that UV irradiation 
could have contributed to the development of PEH 
in her tattoo. 
Unfortunately, tattoo inks are not regulated by the 
FDA as they are considered to be cosmetics and 
additives, whereas in the European Union (EU) they 
are regarded as general consumer products and 
hence, are regulated under the General Product 
Safety Directive (92/59/EEC). It is obvious, therefore,  
Table 2. Reported cases of PEH after tattoo. 
 
 Gender Age Tattoo pigment 
Interval between 
tattoo and onset of 
PEH Treatment Authors 
1 M 25 Red Unknown Unknown Sulzberger 1937
2 M 23 Red  12 months Surgical excision Goldberg 1959
3 M Unknown Red Unknown Unknown Goldstein 1967 
4 M Unknown Red Unknown Unknown Goldstein 1967
5 F 27 Purple 2 months Surgical excision Balfour et al 2003
6 F 59 
Red, green, 
yellow 1 week Surgical excision Cui et al 2007 
7 F 30 Red 1 month Lost to follow up Kluger et al 2008 
8 F 32 Red 4 days Topical cosrticosteroids (partial response) Kluger et al 2008 
9 F 54 Unknown  3 months Topical cosrticosteroids (no response) Kluger et al 2008 
10 F 24 Red 12 months Surgical excision Then et al 2009
11 M 51 Red 1 month after tattoo recoloring Unknown 
de Freitas 
Ferreira 
Hostalácio et al 
2011
12 F 50 Red 1 month Surgical excision 
De Roeck et al 
2012
13 M 31 Red 2 months 
Topical cosrticosteroids 
and surgical excision Breza et al 2013 
14 M 47 Red 
7 months after tattoo 
recoloring
Topical 5-FU (no 
response)
Kazlouskaya et al 
2015
15 F 44 Red  7 – 9 months 
Self-resolution 6 weeks 
after biopsy
Kazlouskaya et al 
2015
16 F 36 Red  Unknown Unknown Kiss et al 2016 
17 F 26 Purple 6 months Intralesional corticosteroids 
Tammaro et al 
2016 
18 F 25 Red 
2 weeks after tattoo 
recoloring with a new 
red color 
Topical and systemic 
corticosteroids (initial 
clearance, relapse after 
10 days)
Conti et al 2017 
19 F 36 Red  
Recently after injections 
of pigment in an 1-year 
tatoo 
Intralesional 
corticosteroids 
Tammaro et al 
2018 
20 F 52 Red  1 year CO2 laser treatment was 
programmed 
Broussard-
Steinberg et al 
2018
Volume 25 Number 5| May 2019| 
25(5): 10 
 
 
- 6 - 
Dermatology Online Journal  ||  Case Presentation
that the manufacturers in the US have no obligation 
to disclose the chemicals contained in these inks and 
that the ingredients of the latter have never been 
tested for safety when injected into the skin [35]. 
Guidelines in a resolution of the Council of the EU 
released in 2008 are: 
1. The maximum permitted concentrations of 
carcinogenic, mutagenic and reproduction-toxic 
substances in tattoo inks were established, and 
2. The necessary conditions for risk evaluation prior 
to performing tattoos and for the appropriate 
information of customers about the health risks of 
the latter were described [2, 32, 36]. 
However, the effectiveness of this resolution is 
practically limited since most inks used for tattooing 
are manufactured in, and can be purchased from 
countries outside the EU [2]. 
The modalities most commonly applied in the 
management of PEH secondary to tattoo include 
surgical excision, topical or intralesional 
corticosteroids, topical 5-FU, or CO2 laser that 
reportedly reveal varying therapeutic efficacy. There 
are also some anecdotal reports on the treatment of 
PEH with photochemotherapy (PUVA), 
phototherapy (narrow band UVB), excimer laser, or 
photodynamic therapy, and topical calcineurin 
inhibitors based on the clinical and histological 
similarity of PEH with hypertrophic lichen planus 
[10]. Our patient was treated with excellent cosmetic 
results by surgical excision, which is the treatment of 
choice, particularly for small and well-defined 
lesions. Carbon dioxide laser treatment is the main 
alternative, especially for larger lesions, as it 
effectively ablates the hypertrophic tissue and leads 
to fragmentation of the pigment particles into 
smaller sizes, which can then be eliminated by 
physiological processes [37, 38]. However, it should 
be kept in mind that the latter may result in a 
significant alteration in the structure and chemical 
properties of red pigment particles associated with 
allergenic or toxic potential [37, 38]. 
 
Conclusion 
The frequency of cutaneous and systemic 
complications secondary to tattoos is constantly 
rising as a result of the increased popularity of 
tattooing process. Red tattoos are associated with an 
increased rate of dermatological complications, 
including SCCs and keratoacanthomas. PEH is a 
rarely reported (and possibly underdiagnosed) 
complication of red and purple tattoos that bears 
considerable clinical and histopathological similarity 
to cutaneous neoplasms, and especially SCCs and 
keratoacanthomas. 
We present herein the case of a 30-year-old woman 
with late-onset PEH (two years) to a red-ink tattoo, 
histologically characterized by lack of the otherwise 
very common lichenoid reaction. We review the 
relevant literature, since an extensive knowledge of 
PEH is mandatory for its early diagnosis and 
appropriate treatment. Finally, since the 
composition, biokinetics, metabolic activation, 
phototoxicity, migratory, and carcinogenic potential 
of tattoo inks still remains unexplored and a constant 
reason of serious concern, we feel obliged to 
emphasize the necessity for urgent implementation 
of updated and standardized regulations worldwide 
with regard to their use in tattooing. On the other 
hand, continuous and concerted efforts should be 
undertaken in order to enhance the awareness 
among tattoo artists and the public with regard to 
the possible serious health risks associated with the 
use in the tattooing process of ink pigments of 
questionable or completely unknown safety. 
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